Sphera Funds Management Ltd. Y M Abs Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$29.16 - $51.96 $3.82 Million - $6.81 Million	-131,016 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$37.86 - $54.26 $10.1 Million - $14.4 Million	-265,505 Reduced 66.96%	131,016 $6.49 Million
Q3 2020 Nov 12, 2020	BUY	$35.13 - $43.62 $4.01 Million - $4.98 Million	114,269 Added 40.48%	396,521 $15.2 Million
Q2 2020 Aug 13, 2020	SELL	$23.66 - $49.53 $594,504 - $1.24 Million	-25,127 Reduced 8.17%	282,252 $12.2 Million
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $1.35 Million - $3.37 Million	94,086 Added 44.11%	307,379 $8.02 Million
Q4 2019 Feb 13, 2020	BUY	$23.81 - $33.78 $554,606 - $786,837	23,293 Added 12.26%	213,293 $6.67 Million
Q2 2019 Aug 14, 2019	BUY	$19.51 - $28.31 $3.71 Million - $5.38 Million	190,000 New	190,000 $0

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.